TABLE OF CONTENTS

1. INTRODUCTION 24
1.1. OBJECTIVES OF THE STUDY 24
1.2. MARKET DEFINITION 24
1.3. OVERVIEW OF GLOBAL ADVANCED WOUND CARE DRESSINGS MARKET 24
1.4. CURRENCY AND PRICING 25
1.5. LIMITATION 25
1.6. MARKETS COVERED 26
2. MARKET SEGMENTATION 28
2.1. MARKETS COVERED 28
2.2. GEOGRAPHIC SCOPE 29
2.3. YEARS CONSIDERED FOR THE STUDY 30
2.4. CURRENCY AND PRICING 30
2.5. RESEARCH METHODOLOGY 31
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 34
2.7. SECONDARY SOURCES 35
2.8. ASSUMPTIONS 35
3. MARKET OVERVIEW 36
3.1. DRIVERS 38
3.1.1. RISING AGING AND GERIATRIC POPULATION 38
3.1.2. TECHNOLOGICAL ADVANCEMENT IN ADVANCED WOUND CARE DRESSINGS PRODUCTS 38
3.1.3. INCREASED NUMBER OF SURGICAL PROCEDURES 39
3.1.4. GOVERNMENT SUPPORT FOR PROMOTING ADVANCED WOUND CARE PRODUCTS 39
3.1.5. RISING INCIDENCE OF DIABETES 40
?
3.2. RESTRAINTS 40
3.2.1. HIGH COST OF PRODUCTS 40
3.2.2. AVAILABILITY OF SUBSTITUTE PRODUCTS 41
3.3. OPPORTUNITIES 41
3.3.1. FAVORABLE REIMBURSEMENT SCENARIO 41
3.3.2. MERGERS AND ACQUISITION BY KEY PLAYERS 42
3.4. CHALLENGES 42
3.4.1. LACK OF SKILLED PROFESSIONALS 42
4. EXECUTIVE SUMMARY 43
5. PREMIUM INSIGHTS 46
6. GLOBAL ADVANCED WOUND CARE DRESSINGS MARKET,
BY PRODUCT TYPE 49
6.1. OVERVIEW 50
6.2. FOAM DRESSING 52
6.3. HYDROGELS 53
6.4. FILM DRESSINGS 54
6.5. ALGINATES 55
6.6. WOUND CONTACT LAYERS 56
6.7. SUPER ABSORBENT DRESSINGS 57
7. GLOBAL ADVANCED WOUND CARE DRESSINGS MARKET,
BY WOUND TYPE 58
7.1. OVERVIEW 59
7.2. SURGICAL WOUND 61
7.3. DIABETIC ULCERS 62
7.4. BURN 63
7.5. PRESSURE ULCERS 64
7.6. VENOUS ULCERS 65
7.7. OTHERS 66
8. GLOBAL ADVANCED WOUND CARE DRESSINGS MARKET, BY END-USER 67
8.1. OVERVIEW 68
8.2. HOSPITALS 70
8.3. WOUND CARE CENTER 71
8.4. AMBULATORY CENTERS 72
8.5. HOME HEALTHCARE 73
8.6. CLINICS 74
8.7. COMMUNITY HEALTHCARE 75
9. GLOBAL ADVANCED WOUND CARE DRESSINGS MARKET,
BY DISTRIBUTION CHANNEL 76
9.1. OVERVIEW 77
9.2. DIRECT TENDERS 79
9.3. RETAIL 80
10. GLOBAL ADVANCED WOUND CARE DRESSINGS MARKET,
BY GEOGRAPHY 81
10.1. OVERVIEW 82
10.2. NORTH AMERICA 89
10.2.1. U.S. 98
10.2.2. CANADA 101
10.2.3. MEXICO 104
10.3. EUROPE 107
10.3.1. GERMANY 117
10.3.2. FRANCE 120
10.3.3. U.K. 123
10.3.4. ITALY 126
10.3.5. SPAIN 129
10.3.6. RUSSIA 132
10.3.7. TURKEY 135
10.3.8. BELGIUM 138
10.3.9. NETHERLANDS 141
10.3.10. SWITZERLAND 144
10.3.11. REST OF EUROPE 147
10.4. ASIA-PACIFIC 148
10.4.1. CHINA 158
10.4.2. JAPAN 161
10.4.3. INDIA 164
10.4.4. SOUTH KOREA 167
10.4.5. AUSTRALIA 170
10.4.6. SINGAPORE 173
10.4.7. THAILAND 176
10.4.8. MALAYSIA 179
10.4.9. INDONESIA 182
10.4.10. PHILIPPINES 185
10.4.11. REST OF ASIA-PACIFIC 188
10.5. SOUTH AMERICA 189
10.5.1. BRAZIL 198
10.5.2. REST OF SOUTH AMERICA 201
10.6. MIDDLE EAST AND AFRICA 202
10.6.1. SAUDI ARABIA 211
10.6.2. SOUTH AFRICA 214
10.6.3. UAE 217
10.6.4. REST OF MIDDLE EAST AND AFRICA 220
11. COMPANY LANDSCAPE 221
11.1. COMPANY SHARE ANALYSIS; NORTH AMERICA 221
11.2. COMPANY SHARE ANALYSIS; EUROPE 222
11.3. COMPANY SHARE ANALYSIS; ASIA-PACIFIC 223
11.4. COMPANY SHARE ANALYSIS; MIDDLE EAST AND AFRICA 224
11.5. COMPANY SHARE ANALYSIS; SOUTH AMERICA 225
12. COMPANY PROFILE. 226
12.1.1. COMPANY OVERVIEW 226
12.1.2. REVENUE ANALYSIS 226
12.1.3. PRODUCT PORTFOLIO 227
12.1.4. RECENT DEVELOPMENTS 227
12.2. SMITH AND NEPHEW 228
12.2.1. COMPANY OVERVIEW 228
12.2.2. REVENUE ANALYSIS 228
12.2.3. PRODUCT PORTFOLIO 229
12.2.4. RECENT DEVELOPMENTS 229
12.3. MOLNLYCKE HEALTHCARE 230
12.3.1. COMPANY OVERVIEW 230
12.3.2. COMPANY SNAPSHOT 230
12.3.3. PRODUCT PORTFOLIO 231
12.3.4. RECENT DEVELOPMENTS 232
12.4. CONVATEC INC. 233
12.4.1. COMPANY OVERVIEW 233
12.4.2. REVENUE ANALYSIS 233
12.4.3. PRODUCT PORTFOLIO 234
12.4.4. RECENT DEVELOPMENTS 234
12.5. 3M 235
12.5.1. COMPANY OVERVIEW 235
12.5.2. REVENUE ANALYSIS 235
12.5.3. PRODUCT PORTFOLIO 236
12.5.4. RECENT DEVELOPMENTS 237
12.6. BAXTER 238
12.6.1. COMPANY OVERVIEW 238
12.6.2. REVENUE ANALYSIS 238
12.6.3. PRODUCT PORTFOLIO 239
12.6.4. RECENT DEVELOPMENTS 239
12.7. COLOPLAST 240
12.7.1. COMPANY OVERVIEW 240
12.7.2. REVENUE ANALYSIS 240
12.7.3. PRODUCT PORTFOLIO 241
12.7.4. RECENT DEVELOPMENTS 241
12.8. ETHICON INC 242
12.8.1. COMPANY OVERVIEW 242
12.8.2. REVENUE ANALYSIS 242
12.8.3. PRODUCT PORTFOLIO 243
12.8.4. RECENT DEVELOPMENTS 243
12.9. DERMA SCIENCES INC 244
12.9.1. COMPANY OVERVIEW 244
12.9.2. REVENUE ANALYSIS 244
12.9.3. PRODUCT PORTFOLIO 245
12.9.4. RECENT DEVELOPMENTS 245
12.10. PAUL HARTMANN LIMITED 246
12.10.1. COMPANY OVERVIEW 246
12.10.2. COMPANY SNAPSHOT 246
12.10.3. PRODUCT PORTFOLIO 247
12.10.4. RECENT DEVELOPMENTS 247
13. RELATED REPORTS 248